Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Desma is a specialty pharmaceutical company headquartered in Madrid, Spain, with a strong focus on the acquisition and commercialization of established, mature pharmaceutical brands. The company operates primarily in the European market, particularly Spain and Italy, managing a diverse portfolio that spans therapeutic areas such as cardiovascular health, endocrinology, and the central nervous system. By acquiring proven medicines from major global pharmaceutical firms, Desma ensures the continued supply and clinical relevance of essential treatments. Their expertise lies in lifecycle management, regulatory affairs, and niche market distribution rather than de novo drug discovery. The company maintains a robust commercial infrastructure to support its portfolio of well-known products like Colestid and Parlodel. Desma's business model is centered on maximizing the value of off-patent assets through strategic marketing and operational efficiency.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Desma.